Prevention of postoperative nausea and vomiting

Annals of Pharmacotherapy

Volumn 41, Issue 1, 2007, Pages 68-78

  Wilhelm, Sheila M ^a   Dehoorne Smith, Michelle L ^b   Kale Pradhan, Pramodini B ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

5 HT3 antagonists; Dexamethasone; Dimenhydrinate; Droperidol; Neurokinin 1; Postoperative nausea and vomiting; Prochlorperazine; Scopolamine

Indexed keywords

2 PROPANOL; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; DIMENHYDRINATE; DOLASETRON MESILATE; DROPERIDOL; GINGER EXTRACT; GRANISETRON; HALOPERIDOL; HYDROXYZINE; INHALATION ANESTHETIC AGENT; METOCLOPRAMIDE; NEUROKININ 1 RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PEPPERMINT OIL; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN ANTAGONIST; UNINDEXED DRUG;

ACCOMMODATION; ACUPRESSURE; ACUPUNCTURE; AGITATION; ANXIETY; AROMATHERAPY; ASTHENIA; ATAXIA; BLOOD PRESSURE; BLURRED VISION; BURNING SENSATION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DEPRESSION; CHILL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFUSION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG USE; ELECTROACUPUNCTURE; EUPHORIA; EVALUATION; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FEVER; FLUID THERAPY; FLUSHING; FLUSHING SENSATION; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPOTENSION; INSOMNIA; LETHARGY; MEDICAL LITERATURE; MEDLINE; MEMORY DISORDER; MYALGIA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; OBSTRUCTIVE JAUNDICE; OXYGEN THERAPY; PERINEAL BURNING; PERINEAL ITCING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PRURITUS; PUBLICATION; QT PROLONGATION; RESTLESSNESS; REVIEW; RISK FACTOR; RISK REDUCTION; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DISEASE; SKIN SENSITIZATION; SOMNOLENCE; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; TACHYCARDIA; THIRST; TRANSCUTANEOUS NERVE STIMULATION; TREMOR; TWITCHING MOTILITY; URINE RETENTION; WARM SENSATION; XEROSTOMIA;

ANTIEMETICS; DRUG THERAPY, COMBINATION; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; RISK FACTORS; SEROTONIN ANTAGONISTS;

EID: 33846455817     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H398     Document Type: Review

References (68)

1. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71.
2. Gan TJ. Postoperative nausea and vomiting: can it be eliminated? JAMA 2002;287:1233-6.
3. Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology 2001;120:263-86.
4. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000;59:213-43.
5. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 1999;56:729-64.
6. Koda-Kimble MA, Young LY. Nausea and vomiting. In: Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Corelli RL, eds. Applied therapeutics: the clinical use of drugs. 6th ed. Vancouver, WA: Applied Therapeutics, 1995:105-1-105-11.
7. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999;93:693-700.
8. Kenny GN. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994;49:6-10.
9. Stadler M, Bardiay F, Seidel L, Albert A, Boogaerts JG. Difference in risk factors of postoperative nausea and vomiting. Anesthesiology 2003; 98:46-52.
10. Tramer MR. Strategies for postoperative nausea and vomiting. Best Pract Res Clin Anaesthesiol 2004;18:693-701.
11. Tramer MR, Fuchs-Buder T. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth 1999;82:379-86.
12. Suntheralingham Y, Asokumar B, Cheng DCH, Chung F. A prospective randomized double blind study of the effect of intravenous fluid therapy on adverse outcomes of outpatient surgery. Anesth Analg 1995;80:682-6.
13. Greif R, Laciny S, Rapf B, Hickle RS, Sessler DI. Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology 1999;91:1246-52.
14. Goll V, Akca O, Greif R, et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 2001;92:112-7.
15. Fan C, Tanhui E, Joshi S, et al. Acupressure treatment for prevention of postoperative nausea and vomiting. Anesth Analg 1997;84:821-5.
16. Lee A, Done ML. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: a meta analysis. Anesth Analg 1999; 88:1362-9.
17. White PF, Issioui T, Hu J, et al. Comparative efficacy of accumulation (Relief Band) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting. Anesthesiology 2002;97:1075-81.
18. Boehler M, Mitterschiffthaler G, Schlager A. Korean hand acupressure reduces postoperative nausea and vomiting after gynecological laparoscopic surgery. Anesth Analg 2002;94:872-5.
19. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: asystematic review of randomized clinical trials. Br J Anaesth 2000;84:367-71.
20. Eberhart LH, Mayer R, Betz O, et al. Ginger does not prevent postoperative nausea and vomiting after laparoscopic surgery. Anesth Analg 2003;96:995-8.
21. Anderson LA, Gross JB. Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea. J Perianesth Nurs 2004;19:29-35.
22. Oddby-Muhrbeck E, Eksborg S, Bergendahl HTG, Muhrbeck O, Lonnqvist PA. Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology 2002;96:1109-14.
23. Chen JJ, Frame DG, White TJ. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures. Arch Intern Med 1998;158:2124-8.
24. Khalil S, Philbrook L, Rabb M, et al. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery. J Clin Anesth 1999;11:596-600.
25. Olsen JC, Keng JA, Clark JA. Frequency of adverse reactions to prochlorperazine in the ED. Am J Emerg Med 2000;18:609-11.
26. Vinson DR, Migala AF, Quesenberry CP. Slow infusion for the prevention of akathisia induced by prochlorperazine: a randomized controlled trial. J Emerg Med 2001;20:113-9.
27. Collins RW, Jones JB, Walthall JDH. Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial. Ann Emerg Med 2001;38:491-6.
28. Vinson DR, Drotts DL. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 2001;37:125-31.
29. Kranke P, Morin AM, Roewer N, et al, The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002;95:133-43.
30. DRUGDEX system. Version 5.1. Greenwood Village, CO: Thomson Micromedex (expires Dec 31, 2006).
31. Ure D, James KS, McNeill M, Booth JV. Glycopyrrolate reduces nausea during spinal anaesthesia for caesarean section without affecting neonatal outcome. Br J Anaesth 1999;82:277-9.
32. McKenzie R, Wadhwa RK, Uy NT, et al. Antiemetic effectiveness of intramuscular hydroxyzine compared with intramuscular droperidol. Anesth Analg 1981;60:783-8.
33. Kothari SN, Boyd WC, Bottcher ML, Lambert PJ. Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial in patients undergoing laparoscopic cholecystectomy. Surg Endosc 2000;14:926-9.
34. Kranke P, Morin AM, Roewer N, Eberhart LH. Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 2002;46:238-44.
35. Kreisler NS, Spiekermann BF, Ascari CM, et al. Small-dose droperidol effectively reduces nausea in a general surgical adult patient population. Anesth Analg 2000;91:1256-61.
36. Henzi I, Sonderegger J, Tramer MR. Systematic review: efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 2000;47:537-51.
37. MedWatch 2001 safety information summaries: Inapsine (droperidol). www.fda.gov/medwatch/safety/2001/safety01.htm#inapsi (accessed 2006 Jun 15).
38. Dershwitz M. Droperidol: should the black box be light gray? J Clin Anesth 2002;14:598-603.
39. Gan T, White P, Scuderi PE, Watcha M, Kovac A. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified (letter)? Anesthesiology 2002;97:287.
40. Buttner M, Walder B, Von Elm E, Tramer MR. Is low dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology 2004;101:1454-63.
41. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999;88:1370-9.
42. Ploati E, Verlato G, Finco G, et al. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. Anesth Analg 1997;85:395-9.
43. Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999;94: 1230-4.
44. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186-94.
45. Tzeng JI, Wang JJ, Ho ST, Rang CS, Liu YC, Lee SC. Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. Br J Anaesth 2000;85:865-8.
46. Liu K, Hsu C, Chia Y. The effective dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg 1999;89:1316-8.
47. Wang JJ, Ho ST, Lee SC, Liu YC, Ho CM. The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg 2000;91:1404-7.
48. Wang JJ, Ho ST, Wong CS, Tzeng JI, Liu HS, Ger LP. Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-Cesarean analgesia. Can J Anaesth 2001;48:185-90.
49. Habib AS, Gan TJ. Evidence based management of postoperative nausea and vomiting: a review. Can J Anaesth 2004;51:326-41.
50. Tramer MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo controlled trials. Anesthesiology 1997;87:1277-89.
51. Zarate E, Watcha MF, White PF, Klein KW, Rego MS, Stewart G. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Anesth Analg 2000;90:1352-8.
52. Walker JB. Efficacy of single dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting. Clin Ther 2001;23:932-8.
53. Korttila K, Clergur F, Lesser J, et al. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Acta Anaesthesiol Scand 1997;41:914-22.
54. Graczyk SG, McKenzie R, Kallar S, et al. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery. Anesth Analg 1997;84:325-30.
55. Mikawa K, Takao Y, Nishina K, Shiga M, Maekawa N, Obara H. Optimal dose of granisetron for prophylaxis against postoperative emesis after gynecological surgery. Anesth Analg 1997;85:652-6.
56. Wilson AJ, Diemunsch P, Lindeque BG, et al. Single dose intravenous granisetron in the prevention of postoperative nausea and vomiting. Br J Anaesth 1996;76:515-8.
57. Tang J, D'Angelo R, White PF. The efficacy of RS-25259, a long-acting selective 5-HT3 receptor antagonist, for preventing postoperative nausea and vomiting after hysterectomy procedures. Anesth Analg 1998;87:462-7.
58. Gesztesi Z, Scuderi PE, White PF, et al. Substance P (Neurokinin 1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology 2000;93:931-7.
59. Diemunsch P, Schoeffler P, Bryssine B, et al. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br J Anaesth 1999;82:274-6.
60. Diemuncsh PA, Apfel C, Phillip B, Gan TJ, Reiss TR. NK1 antagonist aprepitant vs ondansetron for prevention of PONV: combined data from 2 large trials (abstract A125). Presented at: American Society of Anesthesiologists 2006 Annual Meeting, Chicago, IL, October 14-18, 2006.
61. Eberhart LHJ, Morin AM, Bothner U, Georgieff M. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis or postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 2000;44:1252-7.
62. Kazemi-Kjellberg F, Henzi I, Tramer MR. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol 2001;1:2.
63. Tramer MR, Phillips C, Reynolds DJM, et al. Cost-effectiveness of ondansetron for postoperative nausea and vomiting. Anaesthesia 1999; 54:226-34.
64. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000;92:958-67.
65. Frighetto L, Loewen PS, Dolman J, et al. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery. Can J Anaesth 1999;46:536-43.
66. Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996;83:304-13.
67. Chang P, Okamoto M, Chen J, and Frame D. Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting. J Manag Care Pharm 2005;11:317-21.
68. Wang S, Greco J, Joseph RA, Feuerman M, Malone B. Evaluation of three 5-HT3 receptor antagonists in the prevention of postoperative nausea and vomiting in adults. P&T 2005;30:341-53.